Cash flows from operating activities: | |
Net income | |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation expense | 65.43M |
Amortization of acquired intangible assets | |
Share-based compensation expense | 101.85M |
Accretion of debt discount | 22.34M |
Loss on extinguishment of debt | |
Contingent compensation expense | |
Gain on acquisition | |
Incremental tax benefit related to stock options exercised | -109.93M |
Deferred income taxes | |
Other non-cash adjustments | 5.19M |
Changes in operating assets and liabilities: | |
Accounts receivable | 5M |
Inventory | -41.76M |
Prepaid expenses and other current assets | 3.57M |
Other assets | |
Accounts payable | |
Accrued liabilities | -57.33M |
Other long-term liabilities | |
Unrealized gain on foreign exchange | |
Net cash provided by operating activities | 407.09M |
Cash flows from investing activities: | |
Purchases of available-for-sale securities | -679.06M |
Sales and maturities of available-for-sale securities | |
Sales and maturities of trading securities | |
Net cash paid for acquisitions | -17.84M |
Purchases of investments | |
Purchases of property and equipment | -178.35M |
Cash paid for intangible assets | 11.49M |
Net cash used in investing activities | -341.25M |
Cash flows from financing activities: | |
Payments on current portion of long-term debt | |
Proceeds from issuance of convertible notes | |
Incremental tax benefit related to stock options exercised | 109.93M |
Common stock repurchases | -113.08M |
Proceeds from exercises of warrants | |
Proceeds from issuance of common stock | 47.16M |
Net cash provided by financing activities | -41.22M |
Effect of exchange rate changes on cash and cash equivalents | 1.31M |
Net increase in cash and cash equivalents | 25.93M |
Cash and cash equivalents at beginning of period | 768.77M |
Cash and cash equivalents at end of period | 794.7M |